Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 7:11 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 97–120 of 1,737 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Synucleinopathy Clear all

Conditions: Rapid Eye Movement Sleep Behavior Disorder
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 40 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson Disease, Essential Tremor, Multiple Sclerosis, Dystonia
Interventions: Therapeutic Stimulation Patterns, Symptogenic Stimulation Patterns; Procedure
Lead sponsor: Duke University; Other
Eligibility: 21 Years to 80 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2027
U.S. locations: 3
States / cities: Gainesville, Florida • Atlanta, Georgia • Durham, North Carolina

Conditions: Parkinson's Disease, Depression
Interventions: Ketamine Infusion, Placebo - Saline Infusion; Drug · Other
Lead sponsor: Yale University; Other
Eligibility: 40 Years to 80 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Parkinson Disease
Interventions: Virtual reality bicycling; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 45 Years to 80 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Low Blood Pressure, Parkinsons Disease
Interventions: Nicotine gum; Dietary Supplement
Lead sponsor: New York Institute of Technology; Other
Eligibility: Not listed
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Old Westbury, New York

Conditions: Parkinson's Disease, Tremor, Dystonia
Interventions: Alteration of DBS stimulator settings; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 19 Years and older
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Parkinson Disease
Interventions: Subcortical Stimulation; Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 125 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Parkinson's Disease
Interventions: low-intensity transcranial electrical stimulation, transcranial ultrasound; Procedure
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 40 Years and older
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Parkinson's Disease
Interventions: niacin, placebo; Dietary Supplement · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 35 Years and older
Enrollment: 47 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Augusta, Georgia

Conditions: Parkinson Disease
Interventions: Group A - Early Imaging, Group B - Delayed Imaging; Radiation
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Parkinson Disease, Idiopathic Parkinson Disease
Interventions: [F-18] Fluorodopa Positron Emission Tomography, OM Meditation; Drug · Behavioral
Lead sponsor: Andrew Newberg; Other
Eligibility: 25 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Parkinson Disease
Interventions: Citalopram 20mg, Placebo; Drug
Lead sponsor: University of Michigan; Other
Eligibility: 65 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Parkinson Disease
Interventions: Physical Therapy; Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 30 Years and older
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Parkinson Disease
Interventions: Social Cycling Group, coaching calls, No coaching calls; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 45 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Parkinson's Disease
Interventions: Lokomat; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Parkinson's Disease
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 65 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Parkinson Disease 6, Early-Onset, Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human, Parkinson Disease Autosomal Recessive, Early Onset, Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Parkinson Disease
Interventions: ursodeoxycholic acid; Drug
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Amyotrophic Lateral Sclerosis, Parkinson Disease, Dysphagia
Interventions: Videofluoroscopic Swallowing Examination, Tongue Strength Measurement; Diagnostic Test · Other
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Parkinson's Disease
Interventions: Not listed
Lead sponsor: Rush University Medical Center; Other
Eligibility: 30 Years to 90 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Parkinson's Disease
Interventions: CD-LD IR, IPX203 180 mg, IPX203 270 mg, Rytary 195 mg, Rytary 145 mg; Drug
Lead sponsor: Impax Laboratories, LLC; Industry
Eligibility: 40 Years and older
Enrollment: 26 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 11
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Fountain Valley, California + 8 more

Conditions: Constipation, Parkinson's Disease
Interventions: Lubiprostone; Drug
Lead sponsor: University of Arkansas; Other
Eligibility: 50 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Pure Autonomic Failure, Multiple System Atrophy, Parkinson's Plus Syndromes
Interventions: Not listed
Lead sponsor: Vanderbilt University; Other
Eligibility: 50 Years to 75 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Parkinson's Disease, Essential Tremor, Dystonia
Interventions: Activa RC; Device
Lead sponsor: MedtronicNeuro; Industry
Eligibility: 7 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Cincinnati, Ohio • Nashville, Tennessee + 2 more

Search by objective public record fields.

Sleep Profiles in REM Sleep Behavior Disorder

Effects of Stimulation Patterns of Deep Brain Stimulation

Ketamine for the Treatment of Depression in Parkinson's Disease

Immersive Virtual Reality Bicycling for Persons With Parkinson's Disease

The Effects of Nicotine Chewing Gum in Parkinson's Disease

Effect of Deep Brain Stimulation (DBS) on Sleep Architecture in Patients With Movement Disorders

Intracranial Recordings to Characterize Action Regulation Mechanisms

Non-invasive Neurostimulation in Parkinson's Disease

GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures

Pilot Study To Assess Effect of Treatment and Adherence in PD Subjects

Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA

Citalopram as a Posterior Cortical Protective Therapy in Parkinson Disease

Physical Therapy and Deep Brain Stimulation in Parkinson Disease

In-home Cycling for Individuals With PD: Effectiveness

Effect of Robot-assisted Gait Training on Freezing of Gait in Parkinson's Disease

Fatigue and Cardiac Sympathetic Denervation in Parkinson Disease

Hereditary Parkinson s Disease Natural History Protocol

Brain Bioenergetics in Parkinson's Disease and Response to Repeated Oral UDCA Treatment

Physiological Flow of Liquids Used in Dysphagia Management (Neuro)

Evaluation of a Biomarker Related to the GI Tract for the Diagnosis of Parkinson's Disease

A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

Lubiprostone as a Treatment for Constipation in Parkinson's Disease

Autonomic Failure Patients for RNA Blood Sampling

RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)